Basiliximab in Moderate to Severe Ulcerative Colitis

NCT00430898 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

181

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Basiliximab

Sponsor

Cerimon Pharmaceuticals